The global fungal keratitis treatment market was valued at USD 0.90 billion in 2023, growing at a CAGR of 5.1% from 2024 to 2033. The market is expected to reach USD 1.48 billion by 2033. The market for fungal keratitis treatments is driven by the rising incidence of fungal keratitis globally, rising public awareness of its possible risks, and technical advancements in its cures.
Several fungi can cause fungal keratitis, an infection that affects the cornea, the transparent layer that covers the coloured part of the eye. Aspergillus, Candida, and Fusarium species are a few of them. The growing incidence of fungal keratitis worldwide exacerbates the need for efficient treatment alternatives. Technological developments in diagnostics facilitate the early identification of fungal keratitis, allowing for prompt intervention and therapy. In March 2023, the National Library of Medicine published an article stating that the need for better diagnostic procedures for fungal keratitis stemmed from the shortcomings of existing methods, like the cultural method and direct microscopy with staining, which may require modifications for prompt and precise identification. The need for improved diagnostic tools has been sparked by the condition's rising morbidity and its expanding medical, societal, and economic significance. In this regard, PCR diagnostic techniques have grown in popularity and are now standard procedures in several medical specialities. Because of its high sensitivity of 94%, ability to identify the species of the pathogenic fungus, and speedy findings in 4 hours, PCR diagnostics is promising for diagnosing fungal keratitis.
Get an overview of this study by requesting a free sample
In November 2020, Viatris Inc. was formed when Pfizer Inc. completed the spin-off of its Upjohn Business and combined it with Mylan N.V.
In September 2020, A deal was made for Bausch Health Companies Inc. to purchase Allegro Ophthalmics' entire ophthalmic asset portfolio.
The increasing prevalence of fungal keratitis disease- The worldwide rise in fungal keratitis incidence positively impacts the market's overall growth. In the past, 1,051,787 instances of fungal keratitis were reported annually, with the highest frequency occurring in Asia and Africa. If it were assumed that every instance of fungus was culture-negative, the annual incidence would be between 8 and 11%. Subtropical and tropical regions exhibit the highest annual prevalence of fungal keratitis and the highest ratio of fungal to bacterial causes of microbial keratitis, especially among male agricultural labourers. In addition, a growing number of people are developing fungal keratitis due to contact lens use. Consequently, the increasing number of contact lens wearers who risk getting fungal keratitis drives the market's expansion. The data above shows that fungal keratitis is becoming more common, contributing to the market's growth.
Side effects fungal keratitis treatment- Side effects from fungal keratitis treatment can include swelling of the eyelids, excruciating pain and soreness in the eyes, redness in the eyes, a feeling of something being stuck in the eyes, pus or other discharge, impaired vision, sensitivity to light, and redness in the eyes. Aside from being frequently safe and well-tolerated, these medications only have a small chance of mild side effects. Furthermore, it has been discovered that individuals who use counterfeit medications to treat fungal keratitis encounter a variety of unfavourable side effects.
Increasing R&D- Several attempts have been made to develop and identify novel antifungal treatments for fungal keratitis. A randomized double-asked clinical trial for a combination treatment of 5% natamycin and 1% voriconazole for fungal keratitis was carried out in September 2018 by the L.V. Prasad Eye Institute. In addition, Phase IV studies will likely soon begin at the research centre. Therefore, if these trials are fruitful, a novel drug might be created, which would probably encourage market growth in the years to come.
The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the most significant global fungal keratitis treatment market, with a 42.3% market revenue share in 2023.
Due to the rising incidence of fungal keratitis and new developments in the field, North America is anticipated to lead the global market for fungal keratitis treatments. Due to the growing number of patients with fungal keratitis and other chronic eye disorders and rising research and development costs, the United States is anticipated to lead the overall fungal keratitis treatment market in the North American region throughout the projected period. In humid and warm areas of the United States, fungal keratitis is fairly frequent.
North America Region Fungal Keratitis Treatment Market Share in 2023 - 42.3%
www.thebrainyinsights.com
Check the geographical analysis of this market by requesting a free sample
The route of administration segment is divided into oral, topical, and injection. The topical segment dominated the market, with a market share of around 43% in 2023. Topical antifungals are the most often used medications for treating fungal keratitis. They can be purchased commercially or made into eye drops from a systemic formulation. The only topical antifungal medication authorised for use in the treatment of fungal keratitis is natamycin.
The distribution channel segment is divided into drug stores, hospitals, and others. The hospital segment dominated the market, with a share of around 41% in 2023. Hospitals are essential to managing fungal keratitis cases because they offer various medical services, such as medicine administration, prescription writing, and diagnostics. In addition to providing patients with adequate medical care for fungal keratitis, hospitals guarantee that patients have access to important pharmaceuticals, such as antifungal drugs.
Report Description:
Attribute | Description |
---|---|
Market Size | Revenue (USD Billion) |
Market size value in 2023 | USD 0.90 Billion |
Market size value in 2033 | USD 1.48 Billion |
CAGR (2024 to 2033) | 5.1% |
Historical data | 2020-2022 |
Base Year | 2023 |
Forecast | 2024-2033 |
Region | The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country level. |
Segments | Route of Administration, Distribution Channel |
As per The Brainy Insights, the size of the fungal keratitis treatment market was valued at USD 0.90 billion in 2023 to USD 1.48 billion by 2033.
The global fungal keratitis treatment market is growing at a CAGR of 5.1% during the forecast period 2024-2033.
North America emerged as the largest fungal keratitis treatment market.
This study forecasts global, regional, and country revenue from 2020 to 2033. The Brainy Insights has segmented the global fungal keratitis treatment market based on the below-mentioned segments:
Global Fungal Keratitis Treatment Market By Route of Administration:
Global Fungal Keratitis Treatment Market By Distribution Channel:
Global Fungal Keratitis Treatment Market By Region:
Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision.
Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.
The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.
Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:
The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.
The data procurement stage involves in data gathering and collecting through various data sources.
This stage involves in extensive research. These data sources includes:
Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:
Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.
Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.
The supply side for a domain specific market is analysed by:
The demand side for the market is estimated through:
In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.
Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:
Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:
Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.
This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.
Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.
The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:
Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.
Free Customization
Fortune 500 Clients
Free Yearly Update On Purchase Of Multi/Corporate License
Companies Served Till Date